Precision Oncology Market: Is 2026 the Year "Living...

toegevoegd een audio Health

2026-02-11 11:07:26 -

Precision Oncology Market: Is 2026 the Year "Living Drugs" and AI Become the Standard of Care?

In early 2026, the Precision Oncology Market has reached a massive global valuation, estimated at approximately $146 billion to $190 billion. This year, the industry is witnessing a seismic shift from "Broad-Spectrum Treatments" to "Hyper-Targeted Biologics" that account for nearly 60% of market revenue. This innovation is a primary driver for the market, as the integration of AI-driven...

0 Reacties 0 aandelen 141 Views 0 voorbeeld